DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)

Add to watchlist

$2.78 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 111 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 56.5% .

All

			Value		Shares		↓ Weighting
AUXL		AUXILIUM PHARMACEUTICALS INC	$215,504,000	+15.2%	6,267,382	0.0%	7.74%	+13.5%
ASPX	Buy	AUSPEX PHARMACEUTICALS INC	$154,769,000	+140.0%	2,949,103	+17.4%	5.56%	+136.5%
HZNP	Buy	HORIZON PHARMA PLC	$150,801,000	+122.4%	11,699,047	+111.9%	5.42%	+119.3%
AGN	Buy	ALLERGAN INC	$128,957,000	+47.3%	606,601	+23.4%	4.63%	+45.1%
FLML		FLAMEL TECHNOLOGIES SAsponsored adr	$90,078,000	+19.7%	5,258,475	0.0%	3.24%	+18.0%
AAVL	Sell	AVALANCHE BIOTECHNOLOGIES IN	$87,192,000	+24.5%	1,614,669	-21.1%	3.13%	+22.7%
NXTM	Sell	NXSTAGE MEDICAL INC	$86,270,000	+7.0%	4,811,494	-21.7%	3.10%	+5.4%
	New	HORIZON PHARMA INCnote 5.000%11/1	$82,435,000	–	31,760,461	+100.0%	2.96%	–
BLUE	Sell	BLUEBIRD BIO INC	$78,047,000	+72.8%	850,932	-32.4%	2.80%	+70.4%
		AMAG PHARMACEUTICALS INCnote 2.500% 2/1	$74,866,000	+24.1%	45,020,000	0.0%	2.69%	+22.3%
INFI	Sell	INFINITY PHARMACEUTICALS INC	$65,158,000	+25.0%	3,857,805	-0.6%	2.34%	+23.3%
RNA	Buy	PROSENSA HLDG N V	$62,183,000	+183.9%	3,316,434	+27.6%	2.23%	+179.9%
VNDA	Buy	VANDA PHARMACEUTICALS INC	$59,282,000	+163.3%	4,139,787	+90.9%	2.13%	+159.4%
EHTH		EHEALTH INC	$56,434,000	+3.3%	2,264,588	0.0%	2.03%	+1.8%
ARRY	Sell	ARRAY BIOPHARMA INC	$55,978,000	+28.5%	11,834,595	-3.0%	2.01%	+26.6%
AERI	Sell	AERIE PHARMACEUTICALS INC	$54,262,000	+12.8%	1,858,917	-20.0%	1.95%	+11.2%
UAM	Sell	UNIVERSAL AMERN CORP NEW	$52,105,000	+8.1%	5,614,798	-6.3%	1.87%	+6.5%
ELGX	Buy	ENDOLOGIX INC	$51,662,000	+94.8%	3,378,787	+35.1%	1.86%	+91.9%
		INTEGRA LIFESCIENCES HLDGS Cnote 1.625%12/1	$50,426,000	-0.5%	47,428,000	0.0%	1.81%	-1.9%
AGN		ALLERGAN INCcall	$42,518,000	+19.3%	200,000	0.0%	1.53%	+17.6%
	Buy	ARRAY BIOPHARMA INCnote 3.000% 6/0	$41,604,000	+39.1%	45,000,000	+32.4%	1.50%	+37.0%
NVRO	New	NEVRO CORP	$40,491,000	–	1,047,093	+100.0%	1.46%	–
HUM		HUMANA INCcall	$40,216,000	+10.2%	280,000	0.0%	1.44%	+8.6%
PACB	Buy	PACIFIC BIOSCIENCES CALIF IN	$40,147,000	+85.9%	5,120,771	+16.4%	1.44%	+83.2%
ACHN	New	ACHILLION PHARMACEUTICALS IN	$35,774,000	–	2,920,300	+100.0%	1.28%	–
INSM	Buy	INSMED INC	$34,678,000	+27.7%	2,241,631	+7.8%	1.25%	+25.9%
	Buy	ENDOLOGIX INCnote 2.250%12/1	$34,562,000	+82.6%	34,925,000	+64.4%	1.24%	+80.0%
	Sell	TESARO INCnote 3.000%10/0	$34,005,000	-34.6%	27,123,000	-45.8%	1.22%	-35.5%
DVA	Sell	DAVITA HEALTHCARE PARTNERS I	$32,947,000	-29.9%	435,000	-32.3%	1.18%	-30.9%
OVAS	Sell	OVASCIENCE INC	$27,728,000	+47.1%	627,050	-44.8%	1.00%	+45.0%
	Buy	ACCURAY INCnote 3.750% 8/0	$24,991,000	+9.9%	24,100,000	+11.6%	0.90%	+8.3%
ARNA	Buy	ARENA PHARMACEUTICALS INC	$24,129,000	-1.5%	6,953,737	+18.9%	0.87%	-2.9%
GSK	Buy	GLAXOSMITHKLINE PLCsponsored adr	$24,075,000	+30.9%	563,300	+40.8%	0.86%	+29.1%
ALIM	Buy	ALIMERA SCIENCES INC	$22,414,000	+123.3%	4,045,826	+118.5%	0.80%	+119.9%
	New	HEARTWARE INTL INCnote 3.500%12/1	$21,778,000	–	20,464,000	+100.0%	0.78%	–
CBST	New	CUBIST PHARMACEUTICALS INC	$21,157,000	–	210,200	+100.0%	0.76%	–
ATRS	Buy	ANTARES PHARMA INC	$20,828,000	+45.5%	8,104,318	+3.6%	0.75%	+43.3%
MCK	Sell	MCKESSON CORP	$19,097,000	-19.6%	92,000	-24.6%	0.69%	-20.8%
GILD	New	GILEAD SCIENCES INCput	$18,852,000	–	200,000	+100.0%	0.68%	–
JUNO	New	JUNO THERAPEUTICS INC	$18,703,000	–	358,149	+100.0%	0.67%	–
LOXO		LOXO ONCOLOGY INC	$18,701,000	-10.5%	1,591,546	0.0%	0.67%	-11.8%
TRUP	Buy	TRUPANION INC	$18,560,000	+50.0%	2,678,176	+84.0%	0.67%	+47.9%
PTLA	Buy	PORTOLA PHARMACEUTICALS INC	$18,565,000	+31.7%	655,559	+17.6%	0.67%	+29.8%
	New	WEBMD HEALTH CORPnote 1.500%12/0	$16,921,000	–	17,000,000	+100.0%	0.61%	–
KERX	Sell	KERYX BIOPHARMACEUTICALS INC	$16,746,000	-1.3%	1,183,484	-4.1%	0.60%	-2.6%
RMD	New	RESMED INC	$16,611,000	–	296,300	+100.0%	0.60%	–
OFIX		ORTHOFIX INTL N V	$16,046,000	-2.9%	533,812	0.0%	0.58%	-4.3%
AMPH	Sell	AMPHASTAR PHARMACEUTICALS IN	$14,821,000	-10.1%	1,276,577	-9.8%	0.53%	-11.5%
TRIV	Sell	TRIVASCULAR TECHNOLOGIES INC	$14,438,000	-34.9%	1,148,575	-25.1%	0.52%	-35.8%
ARAY	New	ACCURAY INC	$14,126,000	–	1,870,943	+100.0%	0.51%	–
DYAX	Sell	DYAX CORP	$13,817,000	-53.8%	982,745	-66.7%	0.50%	-54.5%
IMMU		IMMUNOMEDICS INC	$13,469,000	+29.0%	2,805,972	0.0%	0.48%	+27.4%
PRTO	New	PROTEON THERAPEUTICS INC	$13,160,000	–	1,265,343	+100.0%	0.47%	–
DBVT	New	DBV TECHNOLOGIES S Asponsored adr	$13,080,000	–	482,300	+100.0%	0.47%	–
IMPR	Buy	IMPRIVATA INC	$12,977,000	-13.9%	998,252	+2.8%	0.47%	-15.1%
NSTG	Sell	NANOSTRING TECHNOLOGIES INC	$12,863,000	+17.1%	923,378	-8.0%	0.46%	+15.5%
	New	ALLSCRIPTS HEALTHCARE SOLUTNnote 1.250% 7/0	$12,795,000	–	13,000,000	+100.0%	0.46%	–
MEIP	Buy	MEI PHARMA INC	$12,553,000	+79.8%	2,939,876	+190.6%	0.45%	+77.6%
HTWR	New	HEARTWARE INTL INC	$12,101,000	–	164,800	+100.0%	0.44%	–
INGN	Sell	INOGEN INC	$11,115,000	-2.4%	354,330	-35.8%	0.40%	-3.9%
SAGE	Sell	SAGE THERAPEUTICS INC	$9,612,000	-32.3%	262,625	-41.7%	0.34%	-33.3%
ICPT	Sell	INTERCEPT PHARMACEUTICALS IN	$9,421,000	-59.7%	60,393	-38.8%	0.34%	-60.3%
	New	FLUIDIGM CORP DELnote 2.750% 2/0	$9,144,000	–	10,000,000	+100.0%	0.33%	–
KITE	Sell	KITE PHARMA INC	$8,985,000	-68.8%	155,799	-84.6%	0.32%	-69.3%
PRQR	Sell	PROQR THRAPEUTICS N V	$8,235,000	-9.6%	380,000	-28.3%	0.30%	-10.8%
STRM		STREAMLINE HEALTH SOLUTIONS	$7,893,000	-6.5%	1,822,759	0.0%	0.28%	-7.8%
	New	HEALTHWAYS INCnote 1.500% 7/0	$7,828,000	–	6,700,000	+100.0%	0.28%	–
		ACCURAY INCnote 3.500% 2/0	$7,586,000	+1.5%	5,000,000	0.0%	0.27%	0.0%
TRNX	Sell	TORNIER N V	$7,369,000	-34.3%	288,971	-38.4%	0.26%	-35.2%
CNXR	New	CONNECTURE INC	$7,206,000	–	799,750	+100.0%	0.26%	–
	Sell	SPECTRANETICS CORPmtnf 2.625% 6/0	$6,968,000	-75.7%	5,439,000	-78.6%	0.25%	-76.1%
DSCI	Buy	DERMA SCIENCES INC	$6,718,000	+45.6%	721,546	+30.2%	0.24%	+43.5%
CDNA	Buy	CAREDX INC	$5,829,000	+44.8%	804,000	+39.8%	0.21%	+42.2%
ATEC		ALPHATEC HOLDINGS INC	$5,616,000	-17.1%	3,982,738	0.0%	0.20%	-18.2%
LMNS		LUMENIS LTD	$5,584,000	+4.8%	597,866	0.0%	0.20%	+3.6%
BDSI	New	BIODELIVERY SCIENCES INTL IN	$5,578,000	–	464,083	+100.0%	0.20%	–
RIGL		RIGEL PHARMACEUTICALS INC	$5,443,000	+17.0%	2,397,855	0.0%	0.20%	+15.3%
AXGN	Buy	AXOGEN INC	$5,413,000	+542.9%	1,507,824	+337.1%	0.19%	+525.8%
CASM		CAS MED SYS INC	$5,280,000	-14.9%	3,200,000	0.0%	0.19%	-15.9%
FOMX	Buy	FOAMIX PHARMACEUTICALS LTD	$5,221,000	+114.6%	744,799	+66.8%	0.19%	+111.2%
SCYX	Sell	SCYNEXIS INC	$4,990,000	+19.9%	500,000	-11.2%	0.18%	+17.8%
CARA	Buy	CARA THERAPEUTICS INC	$4,722,000	+46.9%	473,588	+23.6%	0.17%	+45.3%
PFNX	Sell	PFENEX INC	$4,492,000	-25.0%	625,640	-23.1%	0.16%	-26.1%
EGRX		EAGLE PHARMACEUTICALS INC	$4,412,000	+22.5%	284,653	0.0%	0.16%	+21.4%
BEAT	Sell	BIOTELEMETRY INC	$4,303,000	-22.6%	429,000	-48.2%	0.16%	-23.6%
DSCO		DISCOVERY LABORATORIES INC N	$4,245,000	-37.0%	3,659,700	0.0%	0.15%	-37.6%
GNCA	Buy	GENOCEA BIOSCIENCES INC	$4,230,000	-15.7%	604,257	+9.0%	0.15%	-16.9%
KBIO	Sell	KALOBIOS PHARMACEUTICALS INC	$3,956,000	-17.0%	2,286,783	-25.6%	0.14%	-18.4%
THOR	Sell	THORATEC CORP	$3,341,000	-61.3%	102,919	-68.1%	0.12%	-61.9%
MRGE	Sell	MERGE HEALTHCARE INC	$3,179,000	-25.4%	892,897	-53.9%	0.11%	-26.5%
OCRX		OCERA THERAPEUTICS INC	$2,937,000	+30.0%	461,119	0.0%	0.11%	+29.3%
ANTH		ANTHERA PHARMACEUTICALS INC	$2,673,000	-17.7%	1,691,857	0.0%	0.10%	-18.6%
KIN	Sell	KINDRED BIOSCIENCES INC	$2,625,000	-30.8%	352,384	-14.0%	0.09%	-31.9%
IMMU	New	IMMUNOMEDICS INCcall	$2,400,000	–	500,000	+100.0%	0.09%	–
ADPTQ	Sell	ADEPTUS HEALTH INCcl a	$2,358,000	-41.2%	63,053	-60.9%	0.08%	-41.8%
DERM	New	DERMIRA INC	$2,106,000	–	116,267	+100.0%	0.08%	–
FLXN	New	FLEXION THERAPEUTICS INC	$2,016,000	–	99,847	+100.0%	0.07%	–
PARNF	Sell	PARNELL PHARMACEUT HLDGS LTD	$1,559,000	-29.1%	375,700	-1.8%	0.06%	-30.0%
EXEL		EXELIXIS INCcall	$1,440,000	-5.9%	1,000,000	0.0%	0.05%	-7.1%
PTN		PALATIN TECHNOLOGIES INC	$1,460,000	-21.5%	2,000,000	0.0%	0.05%	-23.5%
SLXP	Buy	SALIX PHARMACEUTICALS INC	$1,322,000	+44.6%	11,500	+96.6%	0.05%	+42.4%
EW	New	EDWARDS LIFESCIENCES CORP	$1,274,000	–	10,000	+100.0%	0.05%	–
PTBI	New	PLASMATECH BIOPHARMACEUTICAL	$1,285,000	–	372,374	+100.0%	0.05%	–
ZTS	New	ZOETIS INCcl a	$1,080,000	–	25,097	+100.0%	0.04%	–
ONTY	Sell	ONCOTHYREON INC	$757,000	-82.5%	398,499	-82.3%	0.03%	-82.9%
ILMN	New	ILLUMINA INC	$738,000	–	4,000	+100.0%	0.03%	–
KND	Sell	KINDRED HEALTHCARE INC	$684,000	-62.1%	37,611	-59.6%	0.02%	-62.1%
AGRX		AGILE THERAPEUTICS INC	$645,000	-15.9%	105,000	0.0%	0.02%	-17.9%
MSTX	New	MAST THERAPEUTICS INC	$392,000	–	700,000	+100.0%	0.01%	–
PTBIW	New	PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201	$300,000	–	375,000	+100.0%	0.01%	–
IMRSQ		IMRIS INC	$124,000	+40.9%	147,076	0.0%	0.00%	+33.3%
ELOS	Exit	SYNERON MEDICAL LTD	$0	–	-13,893	-100.0%	-0.01%	–
TBIO	Exit	TRANSGENOMIC INC	$0	–	-68,983	-100.0%	-0.01%	–
IRWD	Exit	IRONWOOD PHARMACEUTICALS INC	$0	–	-36,653	-100.0%	-0.02%	–
HMSY	Exit	HMS HLDGS CORP	$0	–	-29,316	-100.0%	-0.02%	–
SGMO	Exit	SANGAMO BIOSCIENCES INC	$0	–	-50,000	-100.0%	-0.02%	–
PRTA	Exit	PROTHENA CORP PLC	$0	–	-27,500	-100.0%	-0.02%	–
OPK	Exit	OPKO HEALTH INC	$0	–	-75,000	-100.0%	-0.02%	–
WCG	Exit	WELLCARE HEALTH PLANS INC	$0	–	-15,000	-100.0%	-0.03%	–
SEM	Exit	SELECT MED HLDGS CORP	$0	–	-95,321	-100.0%	-0.04%	–
TEAR	Exit	TEARLAB CORP	$0	–	-354,096	-100.0%	-0.04%	–
SNSS	Exit	SUNESIS PHARMACEUTICALS INC	$0	–	-223,625	-100.0%	-0.06%	–
WGBS	Exit	WAFERGEN BIO-SYSTEMS INC	$0	–	-455,201	-100.0%	-0.07%	–
BINDQ	Exit	BIND THERAPEUTICS INC	$0	–	-274,000	-100.0%	-0.09%	–
ALKS	Exit	ALKERMES PLC	$0	–	-55,000	-100.0%	-0.09%	–
FOLD	Exit	AMICUS THERAPEUTICS INC	$0	–	-480,000	-100.0%	-0.10%	–
LPDX	Exit	LIPOSCIENCE INC	$0	–	-679,180	-100.0%	-0.13%	–
CBAY	Exit	CYMABAY THERAPEUTICS INC	$0	–	-513,206	-100.0%	-0.13%	–
OSIR	Exit	OSIRIS THERAPEUTICS INC NEW	$0	–	-388,039	-100.0%	-0.18%	–
THC	Exit	TENET HEALTHCARE CORP	$0	–	-82,960	-100.0%	-0.18%	–
HCA	Exit	HCA HOLDINGS INC	$0	–	-71,303	-100.0%	-0.18%	–
CYBX	Exit	CYBERONICS INC	$0	–	-110,000	-100.0%	-0.20%	–
BSTC	Exit	BIOSPECIFICS TECHNOLOGIES CO	$0	–	-168,883	-100.0%	-0.22%	–
POZN	Exit	POZEN INC	$0	–	-816,254	-100.0%	-0.22%	–
WAGE	Exit	WAGEWORKS INC	$0	–	-190,770	-100.0%	-0.32%	–
TTPH	Exit	TETRAPHASE PHARMACEUTICALS I	$0	–	-450,191	-100.0%	-0.33%	–
ANGO	Exit	ANGIODYNAMICS INC	$0	–	-682,740	-100.0%	-0.34%	–
KERX	Exit	KERYX BIOPHARMACEUTICALS INCput	$0	–	-700,000	-100.0%	-0.35%	–
ABMD	Exit	ABIOMED INC	$0	–	-435,934	-100.0%	-0.40%	–
CMRX	Exit	CHIMERIX INC	$0	–	-406,100	-100.0%	-0.41%	–
ICPT	Exit	INTERCEPT PHARMACEUTICALS INcall	$0	–	-50,000	-100.0%	-0.43%	–
MDT	Exit	MEDTRONIC INC	$0	–	-204,800	-100.0%	-0.46%	–
AET	Exit	AETNA INC NEW	$0	–	-169,194	-100.0%	-0.50%	–
CI	Exit	CIGNA CORPORATION	$0	–	-166,929	-100.0%	-0.55%	–
ANIP	Exit	ANI PHARMACEUTICALS INC	$0	–	-607,355	-100.0%	-0.63%	–
MNKKQ	Exit	MALLINCKRODT PUB LTD COcall	$0	–	-250,000	-100.0%	-0.82%	–
XNPT	Exit	XENOPORT INC	$0	–	-4,438,882	-100.0%	-0.87%	–
GMED	Exit	GLOBUS MED INCcl a	$0	–	-1,278,235	-100.0%	-0.92%	–
WAG	Exit	WALGREEN CO	$0	–	-482,000	-100.0%	-1.04%	–
AET	Exit	AETNA INC NEWput	$0	–	-375,000	-100.0%	-1.11%	–
DRNA	Exit	DICERNA PHARMACEUTICALS INC	$0	–	-2,428,569	-100.0%	-1.13%	–
CI	Exit	CIGNA CORPORATIONput	$0	–	-375,000	-100.0%	-1.24%	–
ABBV	Exit	ABBVIE INC	$0	–	-766,400	-100.0%	-1.61%	–
THC	Exit	TENET HEALTHCARE CORPput	$0	–	-750,000	-100.0%	-1.62%	–
MNKKQ	Exit	MALLINCKRODT PUB LTD CO	$0	–	-510,791	-100.0%	-1.68%	–
HCA	Exit	HCA HOLDINGS INCput	$0	–	-750,000	-100.0%	-1.93%	–
	Exit	VOLCANO CORPORATIONnote 1.750%12/0	$0	–	-75,500,000	-100.0%	-2.38%	–
	Exit	DENDREON CORPnote 2.875% 1/1	$0	–	-222,732,000	-100.0%	-5.52%	–

Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Flynn Management LLC #1

Original filings

The following EDGAR filing(s) were analyzed to create this report:

View 13F-HR filed 2015-02-17

Signatures

The EDGAR filing(s) were signed by:

Flynn Management LLC, its general partner James E. Flynn — Managing Member

Top long-term holdings

Name	Quarters owned	Latest quarter owned	Max weighting
AERIE PHARMACEUTICALS INC	36	Q3 2022	3.6%
CENTENE CORP DEL	30	Q3 2023	3.0%
BIOCRYST PHARMACEUTICALS INC	29	Q3 2023	2.2%
MOLINA HEALTHCARE INC	26	Q3 2022	1.7%
EHEALTH INC	25	Q3 2020	2.0%
INTERCEPT PHARMACEUTICALS IN	24	Q1 2023	2.2%
MYLAN NV	23	Q3 2020	6.2%
PORTOLA PHARMACEUTICALS INC	23	Q1 2019	6.0%
BROOKDALE SR LIVING INC	23	Q3 2023	2.2%
ALIMERA SCIENCES INC	23	Q3 2019	0.8%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.

Latest significant ownerships (13-D/G)

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) Q4 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
	Filed	Shares	Percentage
DA32 Life Science Tech Acquisition Corp.	August 01, 2023	5,145,000	91.1%
CareMax, Inc.	March 13, 2023	18,691,423	16.4%
CareMax, Inc.	June 02, 2022	18,691,423	20.7%

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.

Latest filings

Type	Filed
3	2024-03-19
4	2024-03-19
4	2024-03-12
3	2024-03-08
4	2024-02-16
13F-HR	2024-02-14
4	2024-02-08
3	2024-02-01
4	2023-11-21
13F-HR	2023-11-14

View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.

All filings

View complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

The reported total value is incorrect (2783541000.0 != 2783542000.0)

Export DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s holdings

DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) - Q4 2014 holdings